| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/1992 | EP0464135A1 Method for reducing side effects of a drug. |
| 01/08/1992 | EP0349535B1 New dental composition and a process for the preparation thereof |
| 01/08/1992 | EP0319576B1 Prostaglandin derivatives, processes for preparing them and pharmaceutical compositions containing said derivatives |
| 01/08/1992 | EP0256069B1 Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base |
| 01/08/1992 | EP0215108B1 Compositions for treating acne vulgaris and methods of making same |
| 01/08/1992 | EP0190265B1 Pyridone esters as inotropic agents |
| 01/08/1992 | EP0179807B1 Stable pharmaceutical compositions of short-acting beta-adrenergic receptor blocking agents |
| 01/08/1992 | EP0160051B1 Foamable biocide composition |
| 01/08/1992 | EP0147461B1 11-halogene-prostane derivatives, process for obtaining them and utilization thereof as drugs |
| 01/08/1992 | CN1057654A Bisphosphonic acid derivatives, their production and use |
| 01/08/1992 | CN1057653A Difluoroglutamic acid conjugates with folates and anti-folates for treatment of neoplastic diseases |
| 01/08/1992 | CN1057652A Process for preparing substituted acyclic nucleosides and intermediates occurring therein |
| 01/08/1992 | CN1057651A Process for preparing pyrimidinyl compounds |
| 01/08/1992 | CN1057649A 2,4-and 2,5-substituted pyridine-n-oxides, process for their preparation and their use |
| 01/08/1992 | CN1057647A 3, 3 dithiobis (propionic acids) and esters thereof |
| 01/07/1992 | WO1992000979A1 Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-(thio)ones |
| 01/07/1992 | WO1992000739A1 3-phenyl-5,6-dihydrobenz[c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents |
| 01/07/1992 | WO1992000738A1 Therapeutic use of piperidine-2,6-diones |
| 01/07/1992 | US5079377 Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
| 01/07/1992 | US5079364 Treatment of senile dementia and cerebral insufficiency |
| 01/07/1992 | US5079358 Humans; leukemia |
| 01/07/1992 | US5079357 Derivatives of penem |
| 01/07/1992 | US5079265 Composition and methods for providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (hmlo) |
| 01/07/1992 | US5079264 Chemical process |
| 01/07/1992 | US5079263 Leukocyte elastase enzyme inhibitors; controlling proteolysis |
| 01/07/1992 | US5079262 Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
| 01/07/1992 | US5079261 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/07/1992 | US5079260 Method for treating inflammation and compounds and compositions suitable for use therein |
| 01/07/1992 | US5079259 Pharmaceutically active 9-chloroprostaglandins |
| 01/07/1992 | US5079258 Enzyme inhibitors, antiallergens treatment of asthma |
| 01/07/1992 | US5079257 Antitumor Agents |
| 01/07/1992 | US5079255 Thiazolo [4,5-6] pyridine derivatives and anti-ulcerative composition containing same |
| 01/07/1992 | US5079254 Inhibitors of hexosaminidase enzyme; enzymes-hydrolases |
| 01/07/1992 | US5079253 Composition for the topical treatment of glaucoma or ocular hypertension |
| 01/07/1992 | US5079252 Valeryl ester of acyclovir improves bioavailability of acylclovir, viricides, treatment of herpes |
| 01/07/1992 | US5079250 Tricyclic heterocyclic diols and their preparation and use |
| 01/07/1992 | US5079249 Bis(aryl)alkene pyrrolidine compounds |
| 01/07/1992 | US5079247 N1 -substituted benz(cd)indol-2-imine compounds as cardiovascular agents |
| 01/07/1992 | US5079246 Novel indoloquinlones |
| 01/07/1992 | US5079245 2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes |
| 01/07/1992 | US5079244 Cardiovascular disorders including angina pectoris, hypotensive agents |
| 01/07/1992 | US5079243 Benzazepines |
| 01/07/1992 | US5079241 Cephalosporin derivatives and pharmaceutical compositions in which they are present |
| 01/07/1992 | US5079240 Reaction product of natural bile acid with n-alkyl amino acid or analogue |
| 01/07/1992 | US5079237 Improved water solubility |
| 01/07/1992 | US5079236 Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
| 01/07/1992 | US5079235 5-Substituted Pyrimidine Nucleosides |
| 01/07/1992 | US5079234 Inhibitors of aminoglycoside nephrotoxicity |
| 01/07/1992 | US5079233 N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| 01/07/1992 | US5079009 Controlled release compositions including polyethylene oxide with urethane cross-linking |
| 01/07/1992 | US5079007 Controlled release of antibiotic salts from an implant |
| 01/07/1992 | US5079001 Liquid oral formulation of diclofenac |
| 01/07/1992 | US5078999 Method of treating systemic lupus erythematosus |
| 01/07/1992 | US5078995 Fibrionolytic composition |
| 01/07/1992 | US5078706 Preventing agent for human immunodeficiency virus infection comprising menfegol |
| 01/07/1992 | US5078680 Automatic injector for emergency treatment |
| 01/07/1992 | CA2086547A1 Antiviral tetrahydroimidazo [1,4]benzodiazepin-2-(thi)ones |
| 01/07/1992 | CA2086260A1 Therapeutic use of piperidine-2,6-diones |
| 01/07/1992 | CA2086237A1 3-phenyl-5, 6-dihydrobenz¬c|acridine-7carboxylic acids and related compounds as immunosuppressive agents |
| 01/07/1992 | CA2046171A1 Sulfur-substituted mevinic acid derivatives |
| 01/07/1992 | CA2043564A1 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate |
| 01/07/1992 | CA1293972C 1-¬2-(hydroxymethyl)cycloalkylmethyl|-5-substituted uracils |
| 01/07/1992 | CA1293929C Pharmaceutical composition containing nifedipine |
| 01/07/1992 | CA1293924C Nonirritating teat dip and method |
| 01/06/1992 | CA2046264A1 Alpha-mercapto alkylamine n-substituted derivatives, a process for their preparation and intermediate products, their application as pharmacological substances and compositions holding same |
| 01/06/1992 | CA2044636A1 Guanidines |
| 01/05/1992 | WO1992000992A1 ANTI-ANDROGENIC [3,2-c]PYRAZOLE AND [3,2-d]TRIAZOLE STEROIDS |
| 01/05/1992 | CA2086678A1 Anti-androgenic [3,2-c]pyrazole and [3,2-d]triazole steroids |
| 01/04/1992 | CA2046079A1 Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
| 01/04/1992 | CA2046074A1 Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs |
| 01/04/1992 | CA2046040A1 Immunosuppressant fermentation products of a microorganism |
| 01/04/1992 | CA2046037A1 Long-term prophylaxis against diseases caused by viruses or by unconventional viruses |
| 01/04/1992 | CA2045003A1 5-isothiazolamine derivatives |
| 01/03/1992 | WO1992000076A1 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 01/03/1992 | WO1992000064A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 01/03/1992 | CA2045989A1 Heteroatoms-containing tricyclic compounds |
| 01/03/1992 | CA2045327A1 Pyrimidine derivatives which are angiotensin ii receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |
| 01/02/1992 | EP0463989A1 N-oxyimidic acid derivatives |
| 01/02/1992 | EP0463970A1 Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463969A1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them |
| 01/02/1992 | EP0463945A1 Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463944A1 Acylbenzoxazolinones, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463873A1 Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use |
| 01/02/1992 | EP0463861A2 2-(heteroarylsubstituted) phenyl carbapenem antibacterial agents |
| 01/02/1992 | EP0463852A2 2-Phenanthrenyl-carbapenem antibacterial agents |
| 01/02/1992 | EP0463833A2 Controlled release pharmaceutical preparation and process for preparing same |
| 01/02/1992 | EP0463810A1 Heterocyclic compound and psychopharmaceutical composition containing same |
| 01/02/1992 | EP0463756A1 Pyrazolopyrimidinone antianginal agents |
| 01/02/1992 | EP0463712A2 Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections |
| 01/02/1992 | EP0463691A2 Tricyclic sigma ligands |
| 01/02/1992 | EP0463690A1 Antagonists of immunosuppressive macrolides |
| 01/02/1992 | EP0463638A1 Aminophenyl derivatives |
| 01/02/1992 | EP0463636A2 Cardiovascular composition |
| 01/02/1992 | EP0463614A2 The use of the GM1 monosialoganglioside and of its internal ester derivative to prevent the insurgence in man of the tolerance to the analgesic effect of morphine and analogues |
| 01/02/1992 | EP0463596A1 Cerebral function enhancing pyrimidinyl derivatives |
| 01/02/1992 | EP0463592A1 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and for their utilization |
| 01/02/1992 | EP0463560A1 New antiepileptic agents |
| 01/02/1992 | EP0463553A1 Cephalosporin derivative |
| 01/02/1992 | EP0463540A1 Anti-virus agent |
| 01/02/1992 | EP0463514A1 3.3'-Dithiobis (propionic acids) and esters thereof |